Mural Oncologyannounced the appointment of Sachiyo Minegishi to its board of directors, effective September 20. Ms. Minegishi will serve as Chair of the Audit Committee and will also be joining the company’s Nominating and Corporate Governance Committee.She is currently the COO at Rectify Pharmaceuticals.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MURA:
- Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi
- Mural Oncology to host first virtual Investor Day on September 26
- Mural Oncology to Host First Virtual Investor Day on September 26, 2024
- Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mural Oncology to Present at Two Upcoming Investor Conferences